ABCG2 mRNA expression determined by QPCR in human cancer cell lines
Cell/tissue type . | Mean ABCG2 mRNA (SD) . |
|---|---|
| Normal PBMCs | 1.1 (1.0) |
| 8226MR myeloma* | 4402.7 (195.5) |
| 8226 myeloma | 827.4 (30.6) |
| H929 myeloma | 56.1 (3.1) |
| CCRF leukemia | 0.0 (0.0) |
| HL-60 leukemia | 0.0 (0.0) |
| KG1A leukemia | 0.6 (0.1) |
| MCF-7 breast cancer | 37.9 (1.1) |
| MCF-7/mitox† | 5040.4 (589.3) |
| MDA 231 breast cancer | 16.9 (0.2) |
| MDA 361 breast cancer | 0.4 (0.1) |
| A375 melanoma | 13.2 (0.4) |
| SK5 melanoma | 19.7 (2.8) |
| SK28 melanoma | 9.2 (0.3) |
| CRL 1974 melanoma | 29.0 (1.8) |
Cell/tissue type . | Mean ABCG2 mRNA (SD) . |
|---|---|
| Normal PBMCs | 1.1 (1.0) |
| 8226MR myeloma* | 4402.7 (195.5) |
| 8226 myeloma | 827.4 (30.6) |
| H929 myeloma | 56.1 (3.1) |
| CCRF leukemia | 0.0 (0.0) |
| HL-60 leukemia | 0.0 (0.0) |
| KG1A leukemia | 0.6 (0.1) |
| MCF-7 breast cancer | 37.9 (1.1) |
| MCF-7/mitox† | 5040.4 (589.3) |
| MDA 231 breast cancer | 16.9 (0.2) |
| MDA 361 breast cancer | 0.4 (0.1) |
| A375 melanoma | 13.2 (0.4) |
| SK5 melanoma | 19.7 (2.8) |
| SK28 melanoma | 9.2 (0.3) |
| CRL 1974 melanoma | 29.0 (1.8) |